Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models

被引：0
|
作者：
Kaori Fujimoto-Ouchi
Fumiko Sekiguchi
Hideyuki Yasuno
Yoichiro Moriya
Kazushige Mori
Yutaka Tanaka
机构：
[1] Chugai Pharmaceuticals Co.,Product Research Department, Kamakura Research Center
[2] Ltd,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 59卷
关键词：
Trastuzumab; Antitumor activity; Human xenograft models; Gastric cancer; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：795 / 805
页数：10
相关论文
共 50 条
  • [1] Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models
    Fujimoto-Ouchi, Kaori
    Sekiguchi, Fumiko
    Yasuno, Hideyuki
    Moriya, Yoichiro
    Mori, Kazushige
    Tanaka, Yutaka
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (06) : 795 - 805
  • [2] Pertuzumab in Combination with Trastuzumab Shows Significantly Enhanced Antitumor Activity in HER2-Positive Human Gastric Cancer Xenograft Models
    Yamashita-Kashima, Yoriko
    Iijima, Shigeyuki
    Yorozu, Keigo
    Furugaki, Koh
    Kurasawa, Mitsue
    Ohta, Masateru
    Fujimoto-Ouchi, Kaori
    CLINICAL CANCER RESEARCH, 2011, 17 (15) : 5060 - 5070
  • [3] Trastuzumab in combination with paclitaxel enhances antitumor activity by promoting apoptosis in human epidermal growth factor receptor 2-positive trastuzumab-resistant gastric cancer xenograft models
    Shu, Sei
    Yamashita-Kashima, Yoriko
    Yanagisawa, Mieko
    Nakanishi, Hayao
    Kodera, Yasuhiro
    Harada, Naoki
    Yoshimura, Yasushi
    ANTI-CANCER DRUGS, 2020, 31 (03) : 241 - 250
  • [4] Antitumor activity of bevacizumab in combination with capecitabine and oxaliplatin in human colorectal cancer xenograft models
    Yanagisawa, Mieko
    Fujimoto-Ouchi, Kaori
    Yorozu, Keigo
    Yamashita, Yoriko
    Mori, Kazushige
    ONCOLOGY REPORTS, 2009, 22 (02) : 241 - 247
  • [5] Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models
    Ouchi, KF
    Yanagisawa, M
    Sekiguchi, F
    Tanaka, Y
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (05) : 693 - 702
  • [6] Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models
    Kaori F. -Ouchi
    Mieko Yanagisawa
    Fumiko Sekiguchi
    Yutaka Tanaka
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 693 - 702
  • [7] Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models
    Scheuer, Werner
    Friess, Thomas
    Burtscher, Helmut
    Bossenmaier, Birgit
    Endl, Josef
    Hasmann, Max
    CANCER RESEARCH, 2009, 69 (24) : 9330 - 9336
  • [8] Antitumor activity of AMG 706 alone and in combination with chemotherapy against established human tumor xenograft models in nude mice
    Starnes, Charlie O.
    Coxon, Angela
    Scully, Sheila
    Freeman, Dan
    Patel, Vinod
    Tasker, Andrew
    Polverino, Tony
    Kendall, Rick
    Radinsky, Robert
    CANCER RESEARCH, 2006, 66 (08)
  • [9] Investigation of tumoral factors influencing the antitumor activity of bevacizumab in human gastric xenograft models
    Yamashita, Yoriko
    Fujimoto-Ouchi, Kaori
    Yorozu, Keigo
    Kurasawa, Mitsue
    Yanagisawa, Mieko
    Mori, Kazushige
    CANCER RESEARCH, 2009, 69
  • [10] Antitumor effect of Realgar in combination with chemotherapy drugs on human gastric cancer cells
    Zhang, Lian
    Kim, Sungkyoung
    Ding, Wenping
    Zheng, Leizhen
    Zhang, Li
    Tong, Yingying
    Chen, Siyu
    CANCER RESEARCH, 2014, 74 (19)
12345